Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_assertion description "[Together, these results support the view that CD40 activation of B-CLL cells might reverse T-cell anergy against the neoplastic cell clone, although the character of the immune response depends on the major histocompatibility complex (MHC) background on which the CLL or tumor antigens are presented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_assertion evidence source_evidence_literature NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_assertion SIO_000772 10068672 NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_assertion wasDerivedFrom befree-20140225 NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_assertion wasGeneratedBy ECO_0000203 NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP663380.RAdL7E1CAiwpaPi7HTqRYfbInSa2BrHSznEHCtZBkhQqg130_provenance.